Broxaterol

File:Broxaterol.svg

Broxaterol chemical structure

File:Broxaterol synthesis cycloaddition.svg

Synthesis of Broxaterol via cycloaddition.

Broxaterol is a beta-2 adrenergic receptor agonist used primarily in the treatment of asthma and other conditions involving bronchoconstriction. It functions by relaxing the smooth muscles of the bronchi, leading to bronchodilation and improved airflow.

Pharmacology

Broxaterol acts on the beta-2 adrenergic receptors located in the bronchial smooth muscle. Activation of these receptors leads to the activation of adenylate cyclase, which increases the levels of cyclic adenosine monophosphate (cAMP). Elevated cAMP levels result in the relaxation of bronchial smooth muscle and subsequent bronchodilation.

Clinical Use

Broxaterol is indicated for the management of asthma and chronic obstructive pulmonary disease (COPD). It is administered via inhalation, which allows for direct delivery to the lungs, minimizing systemic side effects. The onset of action is rapid, making it suitable for the relief of acute bronchospasm.

Synthesis

The synthesis of Broxaterol involves a cycloaddition reaction, as depicted in the accompanying image. This process is a key step in the formation of the active compound, allowing for the precise construction of its chemical structure.

Mechanism of Action

Broxaterol's mechanism of action is primarily through the stimulation of beta-2 adrenergic receptors. This stimulation leads to a cascade of intracellular events that result in the relaxation of bronchial smooth muscle. The increased cAMP levels inhibit the phosphorylation of myosin light chain kinase, reducing muscle contraction and promoting bronchodilation.

Side Effects

Common side effects of Broxaterol include tremor, tachycardia, and nervousness. These effects are generally mild and result from the systemic absorption of the drug. In rare cases, more severe cardiovascular effects can occur, particularly in patients with pre-existing heart conditions.

Related Pages

• Asthma
• Chronic obstructive pulmonary disease
• Beta-2 adrenergic receptor
• Bronchodilator

Drug groups | Encyclopedia | Dictionary | Cancer drugs | OTC | Alternative meds | Drugs | Medications A-Z | FDA approved products | Portal:Pharmacology